3,465
Views
5
CrossRef citations to date
0
Altmetric
Novel Vaccines – Research Paper

Estimating the burden of adult hospitalized RSV infection using local and state data - methodology

, , &
Article: 1958610 | Received 05 May 2021, Accepted 17 Jul 2021, Published online: 10 Mar 2022

References

  • Karron RA. Respiratory syncytial virus and parainfluenza virus vaccines. In: Plotkin Stanley A, Orenstein Walter A, Offit Paul A, editors. Vaccines. 6th ed. Elsevier; 2013. p.1146–12.
  • Belongia EA, King JP, Kieke BA, Pluta J, Al-Hilli A, Meece J, Shinde V. Clinical features, severity, and incidence of RSV illness during 12 consecutive seasons in a community cohort of adults≥ 60 years old; Oxford University Press US; 2018. p. ofy316.
  • Colosia AD, Yang J, Hillson E, Mauskopf J, Copley-Merriman C, Shinde V, Stoddard J. The epidemiology of medically attended respiratory syncytial virus in older adults in the United States: a systematic review. PloS One. 2017;12(8):e0182321. doi:10.1371/journal.pone.0182321.
  • Htar MTT, Yerramalla M, Moïsi J, Swerdlow D. The burden of respiratory syncytial virus in adults: a systematic review and meta-analysis. Epidemiol Infect. 2020;148.
  • Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med. 2005;352(17):1749–59. doi:10.1056/NEJMoa043951.
  • Pastula ST, Hackett J, Coalson J, Jiang X, Villafana T, Ambrose C, Fryzek J. Hospitalizations for respiratory syncytial virus among adults in the United States, 1997–2012; Oxford University Press US; 2017. p. ofw270.
  • Falsey AR, McElhaney JE, Beran J, Van Essen GA, Duval X, Esen M, Galtier F, Gervais P, Hwang S-J, Kremsner P. Respiratory syncytial virus and other respiratory viral infections in older adults with moderate to severe influenza-like illness. J Infect Dis. 2014;209(12):1873–81. doi:10.1093/infdis/jit839.
  • Anderson NW, Binnicker MJ, Harris DM, Chirila RM, Brumble L, Mandrekar J, Hata DJ. Morbidity and mortality among patients with respiratory syncytial virus infection: a 2-year retrospective review. Diagn Microbiol Infect Dis. 2016;85(3):367–71. doi:10.1016/j.diagmicrobio.2016.02.025.
  • Chatzis O, Darbre S, Pasquier J, Meylan P, Manuel O, Aubert JD, Beck-Popovic M, Masouridi-Levrat S, Ansari M, Kaiser L. Burden of severe RSV disease among immunocompromised children and adults: a 10 year retrospective study. BMC Infect Dis. 2018;18(1):111. doi:10.1186/s12879-018-3002-3.
  • Thornhill EM, Salpor J, Verhoeven D. Respiratory syntycial virus: current treatment strategies and vaccine approaches. Antivir Chem Chemother. 2020 Jan-Dec;28:2040206620947303. doi:10.1177/2040206620947303.
  • Sieling WD, Goldman CR, Oberhardt M, Phillips M, Finelli L, Saiman L. Comparative incidence and burden of respiratory viruses associated with hospitalization in adults in New York City. Influenza Other Respir Viruses. Jan 26 2021. doi: 10.1111/irv.12842
  • Shi T, Denouel A, Tietjen AK, Campbell I, Moran E, Li X, Campbell H, Demont C, Nyawanda BO, Chu HY, et al. Global disease burden estimates of respiratory syncytial virus–associated acute respiratory infection in older adults in 2015: a systematic review and meta-analysis. J Infect Dis. 2020;222(Supplement_7):S577–S583. doi:10.1093/infdis/jiz059.
  • Prasad N, Walker TA, Waite B, Wood T, Trenholme AA, Baker MG, McArthur C, Wong CA, Grant CC, Huang QS, et al. Respiratory syncytial virus associated hospitalizations among adults with chronic medical conditions. Clin Infect Dis. 2020 Jun 12. doi:10.1093/cid/ciaa730.
  • Fleming DM, Taylor RJ, Lustig RL, Schuck-Paim C, Haguinet F, Webb DJ, Logie J, Matias G, Taylor S. Modelling estimates of the burden of Respiratory Syncytial virus infection in adults and the elderly in the United Kingdom. BMC Infect Dis. 2015;15(1):443. doi:10.1186/s12879-015-1218-z.
  • Pitman R, Melegaro A, Gelb D, Siddiqui M, Gay N, Edmunds W. Assessing the burden of influenza and other respiratory infections in England and Wales. J Infect. 2007;54(6):530–38. doi:10.1016/j.jinf.2006.09.017.
  • Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, Fukuda K. Mortality associated with influenza and respiratory syncytial virus in the United States. Jama. 2003;289(2):179–86. doi:10.1001/jama.289.2.179.
  • Simonsen L, Taylor RJ, Young-Xu Y, Haber M, May L, Klugman KP. Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age groups in the United States. MBio. 2011;2(1). doi:10.1128/mBio.00309-10.
  • Chow S-C, Shao J, Wang H, Lokhnygina Y. Sample size calculations in clinical research. CRC press; 2017.
  • Fleiss JL, Levin B, Paik MC. Statistical methods for rates and proportions. John Wiley & Sons; 2013.
  • Ryan TP. Sample size determination and power. John Wiley & Sons; 2013.
  • Robert C. Generalized inverse normal distributions. Stat Probab Lett. 1991;11(1):37–41. doi:10.1016/0167-7152(91)90174-P.
  • Centers for Disease Control and Prevention (CDC). Increased Interseasonal Respiratory Syncytial Virus (RSV) Activity in Parts of the Southern United States. Updated 2021 Jun 10 [accessed 2021 Jun 30]. https://emergency.cdc.gov/han/2021/han00443.asp.
  • Widmer K, Griffin MR, Zhu Y, Williams JV, Talbot HK. Respiratory syncytial virus- and human metapneumovirus-associated emergency department and hospital burden in adults. Influenza Other Respir Viruses. 2014 May;8(3):347–52. doi:10.1111/irv.12234.
  • Widmer K, Zhu Y, Williams JV, Griffin MR, Edwards KM, Talbot HK. Rates of hospitalizations for respiratory syncytial virus, human metapneumovirus, and influenza virus in older adults. J Infect Dis. 2012 Jul 1;206(1):56–62. doi:10.1093/infdis/jis309.
  • McDonald SA, Presanis AM, De Angelis D, van der Hoek W, Hooiveld M, Donker G, Kretzschmar ME. An evidence synthesis approach to estimating the incidence of seasonal influenza in the N etherlands. Influenza Other Respi Viruses. 2014;8(1):33–41. doi:10.1111/irv.12201.
  • Presanis AM, De Angelis D, Hagy A, Reed C, Riley S, Cooper BS, Finelli L, Biedrzycki P, Lipsitch M. The severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysis. PLoS Med. 2009;6(12):e1000207. doi:10.1371/journal.pmed.1000207.
  • Biggerstaff M, Reed C, Epperson S, Jhung MA, Gambhir M, Bresee JS, Jernigan DB, Swerdlow DL, Finelli L. Estimates of the Number of Human Infections With Influenza A(H3N2) Variant Virus, United States, August 2011–April 2012. Clini Infect Dis. 2013;57(suppl_1):S12–S15. doi:10.1093/cid/cit273.
  • Yu H, Cowling BJ, Feng L, Lau EH, Liao Q, Tsang TK, Peng Z, Wu P, Liu F, Fang VJ, et al. Human infection with avian influenza A H7N9 virus: an assessment of clinical severity. Lancet. 2013;382(9887):138–45. doi:10.1016/S0140-6736(13)61207-6.
  • Zimmerman RK, Rinaldo CR, Nowalk MP, Balasubramani GK, Moehling KK, Bullotta A, Eng HF, Raviotta JM, Sax TM, Wisniewski S, et al. Viral infections in outpatients with medically attended acute respiratory illness during the 2012–2013 influenza season. BMC Infect Dis. 2015;15(1):87. doi:10.1186/s12879-015-0806-2.
  • Zimmerman RK, Rinaldo CR, Nowalk MP, Gk B, Thompson MG, Moehling KK, Bullotta A, Wisniewski S. Influenza and other respiratory virus infections in outpatients with medically attended acute respiratory infection during the 2011-12 influenza season. Influenza Other Respir Viruses. 2014 Jul;8(4):397–405. doi:10.1111/irv.12247.
  • Godefroy R, Giraud-Gatineau A, Jimeno M-T, Edouard S, Meddeb L, Zandotti C, Chaudet H, Colson P, Raoult D, Cassir N. Respiratory syncytial virus infection: its propensity for bacterial coinfection and related mortality in elderly adults. Open Forum Infect Dis. 2020 Dec;7(12):ofaa546. doi:10.1093/ofid/ofaa546.
  • Jeannoel M, Lina G, Rasigade JP, Lina B, Morfin F, Casalegno JS. Microorganisms associated with respiratory syncytial virus pneumonia in the adult population. Eur J Clin Microbiol Infect Dis. 2019 Jan;38(1):157–60. doi:10.1007/s10096-018-3407-3.
  • Jung HS, Kang BJ, Ra SW, Seo KW, Jegal Y, Jun J-B, Jung J, Jeong J, Jeon H-J, Ahn J-S. Elucidation of Bacterial Pneumonia-Causing Pathogens in Patients with Respiratory Viral Infection. Tuberc Respir Dis (Seoul). 2017 Oct;80(4):358–67. doi:10.4046/trd.2017.0044.